Protagonist Therapeutics Cash from Operations (TTM) Analysis

Protagonist Therapeutics Inc (PTGX)

26.09 +0.55 (+2.15%) USD | NASDAQ | May 03, 16:00

26.09 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-70.24M
September 30, 2023	-118.83M
June 30, 2023	-117.42M
March 31, 2023	-104.82M
December 31, 2022	-108.14M
September 30, 2022	-103.44M
June 30, 2022	-106.71M
March 31, 2022	-116.78M
December 31, 2021	-107.86M
September 30, 2021	-99.79M
June 30, 2021	-87.61M
March 31, 2021	-85.39M
December 31, 2020	-72.48M
September 30, 2020	-67.91M
June 30, 2020	-65.86M
March 31, 2020	-40.71M
December 31, 2019	-41.53M

Date	Value
September 30, 2019	-37.37M
June 30, 2019	-32.40M
March 31, 2019	-51.47M
December 31, 2018	-49.95M
September 30, 2018	-53.96M
June 30, 2018	-3.981M
March 31, 2018	-0.91M
December 31, 2017	3.872M
September 30, 2017	8.341M
June 30, 2017	-39.34M
March 31, 2017	-35.09M
December 31, 2016	-29.97M
September 30, 2016	-25.03M
June 30, 2016	-21.82M
March 31, 2016	-17.19M
December 31, 2015	-14.38M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-118.83M

Minimum

Sep 2023

-32.40M

Maximum

Jun 2019

-83.44M

Average

-87.61M

Median

Jun 2021

Cash from Operations (TTM) Benchmarks